Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) to
cancer therapy in patients with five aggressive types of
cancer: breast, colorectal,
lung, ovarian
YAN, G.,
ZHANG, L.,
FENG, C.,
GONG, R.,
HUANG, Q.,
HE, M.,
YANG, F.,
LI, Y.,
DING, F.,
MA, W.,
HAN, Z.,
WANG, Z.,
YUAN, Y.,
CAI, B.,
YANG, L.,
GUO, S.,
V.N. Pavlov,
XU, C.,
IDIIATULLINA, E (2018) with
non-irradiated control group. The
cell migration was significantly
inhibited by blue LED irradiation
modified version of Endostar, and the underlying mechanisms. Methods: Colon
cancer cells were treated
GILYAZOVA, I.R.,
KLIMENTOVA, E.A.,
BERMISHEVA, M.A.,
KHUSNUTDINOVA, E.K.,
IZMAILOV, A.A.,
GALIMOVA, E.F.,
SAFIULLIN, R.I.,
GALIMOV, S.N.,
V.N. Pavlov,
BULYGIN, K.V. (2020) in patients with metastatic clear
cell renal
cell carcinoma (ccRCC). Analysis of microRNA expression
Bikkuzin, T.,
Shi, Y.,
Sun, B.,
Guo, Y.,
Jin, X.,
Han, Z.,
V.N. Pavlov,
Zhang, H. (2019) A human corneal stroma induced pluripotent stem
cell (HMUi001-A) line was created from primary
Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) patient. Bioinformatics analysis was conducted and the most significant mutations in prostate
cancerYuan, Y.,
Yan, G.,
Gong, R.,
Zhang, L.,
Liu, T.,
Feng, C.,
Du, W.,
Wang, Y.,
Yang, F.,
Li, Y.,
Guo, S.,
Ding, F.,
Ma, W.,
Idiiatullina, E.,
V.N. Pavlov,
Han, Z.,
Cai, B.,
Yang, L. (2017) types of
cells. The effects of blue LEDs have not been tested on bone marrow-derived mesenchymal stem
Yang, F.,
Yang, L.,
Li, Y.,
Yan, G.,
Feng, C.,
Liu, T.,
Gong, R.,
Yuan, Y.,
Wang, N.,
Idiiatullina, E.,
Bikkuzin, T.,
V.N. Pavlov,
Li, Y.,
Dong, C. (2017) Bone marrow mesenchymal stem
cells (BMSCs) are an expandable population of stem
cells which can